SPONSOR
Fujian Shengdi Pharmaceutical Co., Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 3, Phase 1
Conditions studied: Type 2 DiabetesChronic Management of Body WeightReversal of Neuromuscular Blockade
Fujian Shengdi Pharmaceutical Co., Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Type 2 Diabetes, Chronic Management of Body Weight, Reversal of Neuromuscular Blockade.
The trial portfolio spans Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fujian Shengdi Pharmaceutical Co., Ltd.
How many clinical trials has Fujian Shengdi Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Fujian Shengdi Pharmaceutical Co., Ltd., of which 3 are actively recruiting participants. These trials cover conditions including Type 2 Diabetes, Chronic Management of Body Weight, Reversal of Neuromuscular Blockade. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fujian Shengdi Pharmaceutical Co., Ltd. research focus on?
Fujian Shengdi Pharmaceutical Co., Ltd. clinical trials span Type 2 Diabetes, Chronic Management of Body Weight, Reversal of Neuromuscular Blockade. The research pipeline includes Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fujian Shengdi Pharmaceutical Co., Ltd. clinical trial?
To participate in a Fujian Shengdi Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fujian Shengdi Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Fujian Shengdi Pharmaceutical Co., Ltd.
NCT07060456 Phase 3
Recruiting
Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin
Type 2 Diabetes
NCT07670884 Phase 3
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
Chronic Management of Body Weight
NCT07195604 Phase 1
Recruiting
A Single Ascending Dose of HRS-2162 in Healthy Subjects
Reversal of Neuromuscular Blockade
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology